59 results
Page 2 of 3
8-K
cuf9l9
6 Apr 20
Cost Associated with Exit or Disposal Activities
7:16am
8-K
EX-99.1
shimqgaqifui t5ul
10 Feb 20
Millendo Therapeutics Appoints Christophe Arbet-Engels, MD, PhD, as Chief Medical Officer
8:42am
424B5
p7tg3lck7t8sl
5 Dec 19
Prospectus supplement for primary offering
4:06pm
424B5
kal7qw sg7m1
4 Dec 19
Prospectus supplement for primary offering
4:12pm
8-K
EX-99.1
8m4cir50ay0b20n72vo
29 Mar 19
Millendo Reports Full Year 2018 Operating and Financial Results
7:20am
DEFM14A
tdnx7o
6 Nov 18
Proxy related to merger
12:00am
424B3
fbn2dxnbsknhcsx7jw
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
ak3qj32cq8aj
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
EX-10.6
4msca3argdybva89vh
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm